These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 15314679)

  • 1. Progress on new vaccine strategies against chronic viral infections.
    Berzofsky JA; Ahlers JD; Janik J; Morris J; Oh S; Terabe M; Belyakov IM
    J Clin Invest; 2004 Aug; 114(4):450-62. PubMed ID: 15314679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic vaccines for chronic infections.
    Autran B; Carcelain G; Combadiere B; Debre P
    Science; 2004 Jul; 305(5681):205-8. PubMed ID: 15247470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging human papillomavirus vaccines.
    Christensen ND
    Expert Opin Emerg Drugs; 2005 Feb; 10(1):5-19. PubMed ID: 15757400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic viral infections.
    Woodland DL
    Viral Immunol; 2014 Feb; 27(1):1. PubMed ID: 24494967
    [No Abstract]   [Full Text] [Related]  

  • 5. Designing Chimeric Virus-like Particle-based Vaccines for Human Papillomavirus and HIV: Lessons Learned.
    Eto Y; Saubi N; Ferrer P; Joseph J
    AIDS Rev; 2019; 21(4):218-232. PubMed ID: 31834327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to human papillomavirus.
    Stanley M
    Vaccine; 2006 Mar; 24 Suppl 1():S16-22. PubMed ID: 16219398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to HIV vaccines and potential impact on control of acute HIV-1 infection.
    McElrath MJ
    J Infect Dis; 2010 Oct; 202 Suppl 2(Suppl 2):S323-6. PubMed ID: 20846040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.
    Garnett GP
    J Infect Dis; 2005 Feb; 191 Suppl 1():S97-106. PubMed ID: 15627236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?
    Beckebaum S; Cicinnati VR; Gerken G
    Rev Med Virol; 2002; 12(5):297-319. PubMed ID: 12211043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on HIV vaccines.
    Meldorf M; Corey L
    STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses.
    Inchauspé G; Michel ML
    J Viral Hepat; 2007 Nov; 14 Suppl 1():97-103. PubMed ID: 17958650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new insight into hepatitis C vaccine development.
    Yu CI; Chiang BL
    J Biomed Biotechnol; 2010; 2010():548280. PubMed ID: 20625493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALVAC-HIV vaccines: clinical trial experience focusing on progress in vaccine development.
    Marovich MA
    Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S99-104. PubMed ID: 15285709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in prophylactic and therapeutic vaccines for human papillomavirus infection.
    Stanley MA
    Expert Rev Vaccines; 2003 Jun; 2(3):381-9. PubMed ID: 12903803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle-based vaccines for HIV-1 infection.
    Young KR; Ross TM
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):151-69. PubMed ID: 12769792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for the prevention of cervical cancer by human papillomavirus vaccination.
    Williamson AL; Passmore JA; Rybicki EP
    Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses.
    Báez-Astúa A; Herráez-Hernández E; Garbi N; Pasolli HA; Juárez V; Zur Hausen H; Cid-Arregui A
    J Virol; 2005 Oct; 79(20):12807-17. PubMed ID: 16188983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 immunogen (remune).
    Newsline People AIDS Coalit N Y; 1998 Dec; ():36. PubMed ID: 11367099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented?
    Shaw AR
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S246-8. PubMed ID: 16213009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bicistronic DNA vaccines simultaneously encoding HIV, HSV and HPV antigens promote CD8⁺ T cell responses and protective immunity.
    Santana VC; Diniz MO; Cariri FA; Ventura AM; Cunha-Neto E; Almeida RR; Campos MA; Lima GK; Ferreira LC
    PLoS One; 2013; 8(8):e71322. PubMed ID: 23951135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.